In 2013 there were ~200 million clinical cases of malaria, causing ~600,000 deaths. All antimalarial drugs are now associated with malaria parasite resistance. Thus, new therapies are urgently needed, including new drugs to prevent this disease. We have made the exciting discovery that an existing antimalarial drug can kill malaria parasites in a unique, previously unknown, manner. Here, we will investigate how this occurs and develop new drug candidates for malaria prevention.
The WHO estimates there were ~189 million clinical cases & 584,000 malaria-related deaths in 2013. This translates to ~1,600 child deaths daily. There is no licensed malaria vaccine & all available drugs are associated with resistant parasites. This enormous health issue is driving the search for new therapies. We address this issue by identifying new drug candidates for malaria prevention, with unique modes of action to treatment drugs in order to overcome issues of parasite drug resistance.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE130100090
Funder
Australian Research Council
Funding Amount
$700,000.00
Summary
Three-dimensional cryo electron microscopy facility. The three-dimensional cryo-electron microscopy facility will let us visualise plants, pathogens and nanomachines with resolution not previously possible allowing us to see into cells and diseases with vastly more detail. Our world-class experts will provide regional and national researchers access to cutting-edge technology complementary to the Australian Synchrotron.